XS0601 reduces the incidence of restenosis: A prospective study of 335 patients undergoing percutaneous coronary intervention in China

Chinese Medical Journal

Volumn 119, Issue 1, 2006, Pages 6-13

  Chen, Ke Ji ^a   Shi, Da Zhuo ^a   Xu, Hao ^a   Lü, Shu Zheng ^b   Li, Tian Chang ^c   Ke, Yuan Nan ^d   Zhang, Min Zhou ^e   Lu, Xiao Yan ^a   Sun, Rui Yuan ^f   You, Shi Jie ^g  

^a XIYUAN HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^e GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^f Clinical Drugs Evaluation Center of Anhui Province   (China)

^g FUWAI HOSPITAL   (China)

Author keywords

Angioplasty; Restenosis; Stent; XS0601

Indexed keywords

ACETYLSALICYLIC ACID; CHINESE DRUG; CHUANGXIONGOL; PAEONIFLORIN; PLACEBO; TICLOPIDINE; UNCLASSIFIED DRUG; XS 0601; HERBACEOUS AGENT;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GRANULOCYTOPENIA; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REOPERATION; RESTENOSIS; STATISTICAL SIGNIFICANCE; STOMACH DISEASE; MIDDLE AGED; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STENTS;

EID: 33644989276     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200601010-00002     Document Type: Article

References (29)

1. Grines CL, Rizik D, Levine A, Schreiter T. Colchicine angioplasty restenosis trial (CART) (Abstr). Circulation 1991; 84:11-365.
2. Kent KM, William DO, Cassagneau B, Broderick T. Double blind, controlled trial of the effect of angiopeptin on coronary restenosis following balloon angioplasty (Abstr). Circulation 1993; 88:1-506.
3. Emanuelsson H, Beatt JK, Bagger JP, Balcon R. Long-term effects of angiopeptin treatment in coronary angioplasty: Reduction of clinical events but not angiographic restenosis. Circulation 1995; 91:1689-1696.
4. Whitworth HB, Roubin GS, Hollmann J, Meier B. Effects of nefidipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1986; 8:1271-1276.
5. O'Keefe JH, Giorgi LV, Hartzler GO, Good T. Effects of diltiazem on complications and restenosis after coronary angioplasty. Am J Cardiol 1991; 67:373-376.
6. Grigg LE, Kay TW, Valentine PA, Larkins R. Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid in the incidence of coronary artery restenosis after angioplasty. J Am Coll Cardiol 1989; 13:665-672.
7. Reis GS, Sipperly ME, McCabe CH, Sacks FM. Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet 1989; 2:177-181.
8. Bairati I, Roy L, Meyer F. Double-blind, randomised, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation 1992; 85:950-956.
9. Ellis SG, Roubin GS, Wilentz J, Douglas JS. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 1989; 117:777-782.
10. Faxon D, Spiro T, Minor S, Douglas J. Low molecular weight heparin in prevention of restenosis after angioplasty: Results of enoxaparin restenosis (ERA) trial. Circulation 1994; 90:908-914.
11. Weintraub WS, Boccuzzi SJ, Klein JL, Kosinske AS. Lack of effect of lovastatin on restenosis after coronary angioplasty: Lovastatin restenosis trial study group. N Engl J Med 1994; 331:1331-1337.
12. Beigel Y, Zafrir N, Teplitzky Y, Neumann F. The effect of lovastatin on early restenosis. J Clin Pharmacol 1995; 35:599-605.
13. Knudston ML, Flintoft VF, Roth DL, Hansen JL. Effect of short-term prostacyclin administration on restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1990; 15:691-697.
14. Raizner AE, Hollman J, Abukhalil J, Demke D, for the Ciprostene Investigators. Ciprostene for restenosis revisited: Quantitative analysis of angiograms (Abstr). J Am Coll Cardiol 1993; 21:321A.
15. Serruys PW, Klein W, Tijssen JPG. Effect of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty: A multicenter randomised double-blind placebo-controlled trial. Circulation 1993; 88:1588-1601.
16. Savage MP, Goldberg S, MacDonald RG, Bass TA. Multi-Hospital Eastern Atlantic Restenosis Trial II: A placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplasty. Am Heart J 1991; 122:1239-1243.
17. Serruys PW, Rutsch W, Heyndricks GR, Danchin N. Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. Circulation 1991;84: 1568-1580.
18. Hong MK, Mehran R, Mintz GS, Leon MB. Restenosis after coronary angioplasty. Curr Probl Cardiol 1997; 22:7-36.
19. Wong A, Chan C. Drug-elutting stents: the end of restenosis? Ann Acad Med Singapore 2004;33:423-431.
20. Kereiakes DJ, Choo JK, Young JJ, Broderick TM. Thrombosis and drug-elutting stents: a critical appraisal. Rev Cardiovasc Mad 2004; 5: 9-15.
21. Bhatia V, Bhatia R, Dhindsa M. Drug-eluting stents: new era and new concerns. Postgrad Med J 2004; 80(939): 13-18.
22. Shi DZ, Xu FQ, Li LZ, Ma XC, Wang XF, Chen KJ, et al. The experimental study of Xue Guan Tong on preventing restenosis after percutaneous transluminal angioplasty. Chin J Integr Tradit West Med 1995; 1:284-287.
23. Shi DZ, Li J, Ma XC, Xu FQ, Chen KJ. Clinical observation of concentrated Xuefu Zhuyu Pill on preventing restenosis after percutaneous transluminal coronary angioplasty in patients of coronary heart disease. Chin J TCM (Chin) 1997; 38:27-29.
24. Xu H, Shi DZ, Chen KJ, Wang JH, Ma XC. Effect of Xiongshao capsule on proliferation and apoptosis of vascular smooth muscle cells in rabbits observed by serologic pharmacological method. Chin J Integr Tradit West Med (Chin) 2000; 20:757-760.
25. Xu H, Shi DZ, Chen KJ, Li YL, Meng L, Yuan WM. Effect of XS0601 on apoptosis and gene expression of p53 and bcl-2 in neointima of porcine coronary artery after balloon injury. Chin J Intervent Cardiol (Chin) 2001; 9:152-154.
26. Xu H, Shi DZ, Chen KJ, Li YL, Meng L, Yuan WM. Effect of Xiongshao Capsule on vascular remodeling in porcine coronary balloon injury model. Chin J Integr Tradit West Med 2000; 6: 278-282.
27. Xu H, Chen KJ, Shi DZ, Mao JM, Lv SZ. Clinical study of Xiongshao Capsule in preventing restenosis after coronary interventional treatment. Chin J Integr Tradit West Med 2002;8: 162-166.
28. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong C, et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 1996;94:35-43.
29. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996;94:1247-1254.